• Aarnisalo P, Kim CH, Lee JW, Perlmann T 2002 Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1. J. Biol. Chem. 277: 35118-35123. *

• Akanuma SI, Hori S, Ohtsuki S, Fujiyoshi M, Terasaki T 2008 Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier. Neurochem. Int. 52: 669-674.

• Al-Dosari MS, Knapp JE, Liu D 2006 Activation of human CYP2C9 promoter and regulation by CAR and PXR in mouse liver. Mol. Pharm. 3: 322-328. *

• Alnouti Y, Klaassen CD 2008 Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J. Pharmacol. Exp. Ther. 324: 612-621. *

• Amador-Noguez D, Dean A, Huang W, Setchell K, Moore D, Darlington G 2007 Alterations in xenobiotic metabolism in the long-lived Little mice. Aging Cell 6: 453-470.

• Anakk S, Huang W, Staudinger JL, Tan K, Cole TJ, Moore DD, Strobel HW 2007 Gender dictates the nuclear receptor mediated regulation of CYP3A44. Drug Metab. Dispos. 35: 36-42. *

• Arnold KA, Eichelbaum M, Burk O 2004 Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl. Recept. 2: 1. *

• Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, Evans RM, Moore DD, Borst P, Schuetz JD 2004 Interactions between hepatic Mrp4 and Sult2A as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J. Biol. Chem. 279: 22250-22257. *

• Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, Vilarem MJ, Pascussi JM 2004 Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40: 951-960. *

• Auerbach SS, Dekeyser JG, Stoner MA, Omiecinski CJ 2007 CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristics. Drug Metab. Dispos. 35: 428-439. *

• Auerbach SS, Ramsden R, Stoner MA, Verlinde C, Hassett C, Omiecinski CJ 2003 Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res. 31: 3194-3207. *

• Auerbach SS, Stoner MA, Su S, Omiecinski CJ 2005 Retinoid X receptor-dependent transactivation by a naturally occurring structural variant of human CAR (NR1I3). Mol. Pharmacol. 68: 1239-1253. *

• Bae Y, Kemper JK, Kemper B 2004 Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP). DNA Cell Biol. 23: 81-91.

• Bainy AC 2007 Nuclear receptors and susceptibility to chemical exposure in aquatic organisms. Environ. Int. 33: 571-575.

• Baskin-Bey ES, Anan A, Isomoto H, Bronk SF, Gores GJ 2007 Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse. World J. Gastroenterol. 13: 5635-5641. *

• Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, Craig RW, Moore DD, Gores GJ 2006 Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. Hepatology 44: 252-262. *

• Beaudet MJ, Desrochers M, Lachaud AA, Anderson A 2005 The CYP2B2 phenobarbital response unit contains binding sites for hepatocyte nuclear factor 4, PBX-PREP1, the thyroid hormone receptor beta, and the liver X receptor. Biochem. J. 388: 407-418. *

• Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR 2002 Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun. 293: 145-149. *

• Bell AW, Michalopoulos GK 2006 Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR. Hepatology 44: 186-194. *

• Blattler SM, Rencurel F, Kaufmann MR, Meyer UA 2007 In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 104: 1045-1050. *

• Bock KW, Kohle C 2005 UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Methods Enzymol. 400: 57-75.

• Boyer JL 2005 Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease? Gastroenterology 129: 735-740. *

• Burk O, Arnold KA, Geick A, Tegude H, Eichelbaum M 2005 A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol. Chem. 386: 503-513.

• Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M 2005 Anti-malarial artemisinin drugs induce CYP and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol. Pharmacol. 67: 1954-1965. *

• Burk O, Koch I, Raucy J, Hustert E, Eichelbaum M, Brockmoller J, Zanger UM, Wojnowski L 2004 The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J. Biol. Chem. 279: 38379-38385. *

• Cai Y, Konishi T, Han G, Campwala KH, French SW, Wan YJ 2002 The role of hepatocyte RXR alpha in xenobiotic-sensing nuclear receptor-mediated pathways. Eur. J. Pharm. Sci. 15: 89-96. *

• Cerveny L, Svecova L, Anzenbacherova E, Vrzal R, Staud F, Dvorak Z, Ulrichova J, Anzenbacher P, Pavek P 2007 Valproic acid induces CYP3A4 and MDR1 genes expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab. Dispos. 35: 1032-1041. *

• Chandra P, Brouwer KL 2004 The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm. Res. 21: 719-735. *

• Chang TK, Bandiera SM, Chen J 2003 Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab. Dispos. 31: 7-10. *

• Chang TK, Waxman DJ 2006 Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR). Drug Metab. Rev. 38: 51-73. *

• Chatterjee B, Echchgadda I, Song CS 2005 Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1. Methods Enzymol. 400: 165-191.

• Chen HL, Liu YJ, Chen HL, Wu SH, Ni YH, Ho MC, Lai HS, Hsu WM, Tseng HC, Jeng YM, Chang MH 2008 Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia. Pediatr. Res. 63: 667-673.

• Chen J, Raymond K 2006 Treatment effect of rifampicin on cholestasis. The Internet Journal of Pharmacology Vol. 4 (http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijpharm/vol4n2/colestasis.xml).

• Chen X, Zhang J, Baker SM, Chen G 2007 Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1). Toxicology 231: 224-233. *

• Chen Y, Ferguson SS, Negishi M, Goldstein JA 2004 Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J. Pharmacol. Exp. Ther. 308: 495-501. *

• Cherrington NJ, Slitt AL, Maher JM, Zhang XX, Zhang J, Huang W, Wan YJ, Moore DD, Klaassen CD 2003 Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab. Dispos. 31: 1315-1319. *

• Chiang JY 2005 Nuclear receptor regulation of lipid metabolism: potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver diseases. Curr. Opin. Investig. Drugs 6: 994-1001.

• Cui X, Thomas A, Montgomery D, Gu C, Morrison RA, White RE, Cheng KC 2005 Rat PXR reporter-gene activity correlates with the induction of CYP3A in rat precision-cut liver slices. Comb. Chem. High Throughput Screen. 8: 341-346.

• Dai G, Chou N, He L, Gyamfi MA, Mendy AJ, Slitt AL, Klaassen CD, Wan YJ 2005 RXRalpha regulates the expression of glutathione S-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver. Mol. Pharmacol. 68: 1590-1596. *

• Dai G, Wan YJ 2005 Animal models of xenobiotic receptors. Curr. Drug Metab. 6: 341-355.

• Daly AK 2006 Significance of the minor cytochrome P450 3A isoforms. Clin. Pharmacokinet. 45: 13-31.

• Dickins M 2004 Induction of cytochromes P450. Curr. Top. Med. Chem. 4: 1745-1766.

• Ding X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL 2006 Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J. Biol. Chem. 281: 26540-26551. *

• Ding X, Staudinger JL 2005 The ratio of constitutive androstane receptor to pregnane X receptor determines the activity of guggulsterone against the Cyp2b10 promoter. J. Pharmacol. Exp. Ther. 314: 120-127. *

• Dixit SG, Tirona RG, Kim RB 2005 Beyond CAR and PXR. Curr. Drug Metab. 6: 385-397.

• Duret C, Daujat-Chavanieu M, Pascussi JM, Pichard-Garcia L, Balaguer P, Fabre JM, Vilarem MJ, Maurel P, Gerbal-Chaloin S 2006 Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol. Pharmacol. 70: 329-339. *

• Dvorak Z, Maurel P, Vilarem MJ, Ulrichova J, Modriansky M 2007 Expression and transcriptional activities of nuclear receptors involved in regulation of drug-metabolizing enzymes are not altered by colchicine: focus on PXR, CAR, and GR in primary human hepatocytes. Cell Biol. Toxicol. 23: 63-73. *

• Dvorak Z, Modriansky M, Pichard-Garcia L, Balaguer P, Vilarem MJ, Ulrichova J, Maurel P, Pascussi JM 2003 Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol. Pharmacol. 64: 160-169. *

• Echchgadda I, Song CS, Oh T, Ahmed M, De La Cruz IJ, Chatterjee B 2007 The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase. Mol. Endocrinol. 21: 2099-2111. *

• El-Sankary W, Bombail V, Gibson GG, Plant N 2002 Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab. Dispos. 30: 1029-1034. *

• Faucette SR, Sueyoshi T, Smith CM, Negishi M, Lecluyse EL, Wang H 2006 Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J. Pharmacol. Exp. Ther. 317: 1200-1209. *

• Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski C, Lecluyse E, Negishi M, Wang H 2007 Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J. Pharmacol. Exp. Ther. 320: 72-80. *

• Ferguson SS, Chen Y, Lecluyse EL, Negishi M, Goldstein JA 2005 Human CYP2C8 is transcriptionally regulated by the nuclear receptors CAR, PXR, GR, and HNF4alpha. Mol. Pharmacol. 68: 747-757. *

• Ferguson SS, LeCluyse EL, Negishi M, Goldstein JA 2002 Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol. Pharmacol. 62: 737-746. *

• Finkelstein D, Lamba V, Assem M, Rengelshausen J, Yasuda K, Strom S, Schuetz E 2006 ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics. Xenobiotica 36: 989-1012. *

• Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L 2007 Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol. Med. 13: 298-309. *

• Fisher CD, Augustine LM, Maher JM, Nelson DM, Slitt AL, Klaassen CD, Lehman-McKeeman LD, Cherrington NJ 2007 Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of CAR and NRF2. Drug Metab. Dispos. 35: 995-1000. *

• Fisher CD, Jackson JP, Lickteig AJ, Augustine LM, Cherrington NJ 2008 Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. Arch. Toxicol. May 17 [Epub ahead of print]. *

• Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD 1998 Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 395: 612-615. *

• Frank C, Gonzalez MM, Oinonen C, Dunlop TW, Carlberg C 2003 Characterization of DNA complexes formed by the nuclear receptor constitutive androstane receptor. J. Biol. Chem. 278: 43299-43310. *

• Fuhr U 2000 Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans. Clin. Pharmacokinet. 38: 493-504.

• Gachon F, Olela FF, Schaad O, Descombes P, Schibler U 2006 The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab. 4: 25-36. *

• Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, Lorenzen J, Matern S, Gartung C 2003 Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38: 345-354. *

• Gibson GG, Plant NJ, Swales KE, Ayrton A, El-Sankary W 2002 Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 32: 165-206.

• Gillberg M, Skaanild MT, Friis C 2006 Regulation of gender-dependent CYP2A expression in pigs: involvement of androgens and CAR. Basic Clin. Pharmacol. Toxicol. 98: 480-487.

• Gong H, Xie W 2004 Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential. Expert Opin. Ther. Targets 8: 49-54.

• Gonzalez MM, Carlberg C 2002 Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors. J. Biol. Chem. 277: 18501-18509. *

• Goodwin B, Hodgson E, D'Costa DJ, Robertson GR, Liddle C 2002 Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol. Pharmacol. 62: 359-365. *

• Goodwin B, Moore JT 2004 CAR: detailing new models. Trends Pharmacol. Sci. 25: 437-441. *

• Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA 2001 Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol. 60: 427-431. *

• Greger DL, Blum JW 2007 Effects of dexamethasone on mRNA abundance of nuclear receptors and hepatic nuclear receptor target genes in neonatal calves. J. Anim. Physiol. Anim. Nutr. (Berl.) 91: 62-67. *

• Greger DL, Gropp F, Morel C, Sauter S, Blum JW 2006 Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies. Domest. Anim. Endocrinol. 31: 327-329. *

• Greger DL, Philipona C, Blum JW 2006 Ontogeny of mRNA abundance of nuclear receptors and nuclear receptor target genes in young cattle. Domest. Anim. Endocrinol. 31: 76-87. *

• Gropp FN, Greger DL, Morel C, Sauter S, Blum JW 2006 Nuclear receptor and nuclear receptor target gene messenger ribonucleic acid levels at different sites of the gastrointestinal tract and in liver of healthy dogs. J. Anim. Sci. 84: 2684-2691. *

• Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C 2007 The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 168: 66-73. *

• Guo D, Sarkar J, Ahmed MR, Viswakarma N, Jia Y, Yu S, Sambasiva Rao M, Reddy JK 2006 Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver. Biochem. Biophys. Res. Commun. 347: 485-495. *

• Guo D, Sarkar J, Suino-Powell K, Xu Y, Matsumoto K, Jia Y, Yu S, Khare S, Haldar K, Rao MS, Foreman JE, Monga SP, Peters JM, Xu HE, Reddy JK 2007 Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver. J. Biol. Chem. 282: 36766-36776. *

• Guo GL, Choudhuri S, Klaassen CD 2002 Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways. J. Pharmacol. Exp. Ther. 300: 206-212. *

• Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB Jr, Kliewer SA, Gonzalez FJ, Sinal CJ 2003 Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278: 45062-45071. *

• Handschin C, Blaettler S, Roth A, Looser R, Oscarson M, Kaufmann MR, Podvinec M, Gnerre C, Meyer UA 2004 The evolution of drug-activated nuclear receptors: one ancestral gene diverged into two xenosensor genes in mammals. Nucl. Recept. 2: 7. *

• Handschin C, Meyer UA 2005 Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch. Biochem. Biophys. 433: 387-396. *

• Handschin C, Meyer UA 2003 Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev. 55: 649-673. *

• Handschin C, Podvinec M, Amherd R, Looser R, Ourlin JC, Meyer UA 2002 Cholesterol and bile acids regulate xenosensor signaling in drug-mediated induction of cytochromes P450. J. Biol. Chem. 277: 29561-29567. *

• Handschin C, Podvinec M, Looser R, Amherd R, Meyer UA 2001 Multiple enhancer units mediate drug induction of CYP2H1 by xenobiotic-sensing orphan nuclear receptor chicken xenobiotic receptor. Mol. Pharmacol. 60: 681-689. *

• Handschin C, Podvinec M, Meyer UA 2000 CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U.S.A. 97: 10769-10774. *

• Handschin C, Podvinec M, Stockli J, Hoffmann K, Meyer UA 2001 Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans. Mol. Endocrinol. 15: 1571-1585. *

• Hariparsad N, Carr BA, Evers R, Chu X 2008 Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab. Dispos. 36: 1046-1055. *

• Harmsen S, Meijerman I, Beijnen JH, Schellens JH 2007 The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treat. Rev. 33: 369-380. *

• Hartley DP, Dai X, He YD, Carlini EJ, Wang B, Huskey SE, Ulrich RG, Rushmore TH, Evers R, Evans DC 2004 Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. Mol. Pharmacol. 65: 1159-1171. *

• Healan-Greenberg C, Waring JF, Kempf DJ, Blomme EA, Tirona RG, Kim RB 2008 A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor. Drug Metab. Dispos. 36: 500-507. *

• Hernandez JP, Chapman LM, Kretschmer XC, Baldwin WS 2006 Gender-specific induction of cytochrome P450s in nonylphenol-treated FVB/NJ mice. Toxicol. Appl. Pharmacol. 216: 186-196. *

• Hernandez JP, Huang W, Chapman LM, Chua S, Moore DD, Baldwin WS 2007 The environmental estrogen, nonylphenol, activates the constitutive androstane receptor (CAR). Toxicol. Sci. 98: 416-426. *

• Honkakoski P, Sueyoshi T, Negishi M 2003 Drug-activated nuclear receptors CAR and PXR. Ann. Med. 35: 172-182.

• Hosseinpour F, Moore R, Negishi M, Sueyoshi T 2006 Serine-202 regulates the nuclear translocation of constitutive active/androstane receptor CAR. Mol. Pharmacol. 69: 1095-1102. *

• Hu R, Wu W, Niles EG, Loverde PT 2006 Isolation and characterization of Schistosoma mansoni constitutive androstane receptor. Mol. Biochem. Parasitol. 148: 31-43. *

• Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, Moore DD 2003 Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U.S.A. 100: 4156-4161. *

• Huang W, Zhang J, Moore DD 2004 A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J. Clin. Invest. 113: 137-143. *

• Inoue K, Borchers CH, Negishi M 2006 Cohesin protein SMC1 represses the nuclear receptor CAR-mediated synergistic activation of a human P450 gene by xenobiotics. Biochem. J. 398: 125-133. *

• Itoh M, Nakajima M, Higashi E, Yoshida R, Nagata K, Yamazoe Y, Yokoi T 2006 Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha. J. Pharmacol. Exp. Ther. 319: 693-702. *

• Jackson JP, Ferguson SS, Negishi M, Goldstein JA 2006 Phenytoin induction of the Cyp2c37 gene is mediated by the constitutive androstane receptor. Drug Metab. Dispos. 34: 2003-2010. *

• Jacobs MN, Lewis DF 2002 Steroid hormone receptors and dietary ligands: a selected review. Proc. Nutr. Soc. 61: 105-122. *

• Jia Y, Guo GL, Surapureddi S, Sarkar J, Qi C, Guo D, Xia J, Kashireddi P, Yu S, Cho YW, Rao MS, Kemper B, Ge K, Gonzalez FJ, Reddy JK 2005 Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proc. Natl. Acad. Sci. U.S.A. 102: 12531-12536. *

• Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O 2006 Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. 34: 1756-1763. *

• Jyrkkarinne J, Makinen J, Gynther J, Savolainen H, Poso A, Honkakoski P 2003 Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor. J. Med. Chem. 46: 4687-4695. *

• Jyrkkarinne J, Windshugel B, Makinen J, Ylisirnio M, Perakyla M, Poso A, Sippl W, Honkakoski P 2005 Amino acids important for ligand specificity of the human constitutive androstane receptor. J. Biol. Chem. 280: 5960-5971. *

• Kakizaki S, Yamazaki Y, Kosone T, Horigichi N, Sohara N, Sato K, Takagi H, Yoshinari K, Mori M 2007 Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor. Liver Int. 27: 109-119. *

• Karlsen TH, Boberg KM, Schrumpf E 2006 Role of polymorphisms in genes involved in bile acid detoxification pathways in primary sclerosing cholangitis. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 87. *

• Kassam A, Winrow CJ, Fernandez-Rachubinski F, Capone JP, Rachubinski RA 2000 The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated … J. Biol. Chem. 275: 4345-4350. *

• Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA 2002 Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277: 2908-2915. *

• Kawase A, Tsunokuni Y, Iwaki M 2007 Effects of alterations in CAR on bilirubin detoxification in mouse collagen-induced arthritis. Drug Metab. Dispos. 35: 256-261. *

• Kawase A, Yoshida I, Tsunokuni Y, Iwaki M 2007 Decreased PXR and CAR inhibit transporter and CYP mRNA levels in the liver and intestine of mice with collagen-induced arthritis. Xenobiotica 37: 366-374. *

• Kim J, Min G, Kemper B 2001 Chromatin assembly enhances binding to the CYP2B1 phenobarbital-responsive unit (PBRU) of nuclear factor-1, which binds simultaneously with constitutive androstane receptor (CAR)/retinoid X receptor (RXR) and enhances CAR/RXR-mediated activation … J. Biol. Chem. 276: 7559-7567. *

• Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C 2003 Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 278: 8988-8995. *

• Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR 2004 Suppression of DHEA sulfotransferase (Sult2A1) during the acute phase response. Am. J. Physiol. Endocrinol. Metab. 287: E731-E738. *

• Kleiner HE, Xia X, Sonoda J, Zhang J, Pontius E, Abey J, Evans RM, Moore DD, Digiovanni J 2008 Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice. Toxicol. Appl. Pharmacol. Jul 15 [Epub ahead of print]. *

• Knight TR, Choudhuri S, Klaassen CD 2008 Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers. Toxicol. Sci. Aug 22 [Epub ahead of print]. *

• Kocarek TA, Shenoy SD, Mercer-Haines NA, Runge-Morris M 2002 Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes. J. Pharmacol. Toxicol. Methods 47: 177-187. *

• Kohalmy K, Tamasi V, Kobori L, Sarvary E, Pascussi JM, Porrogi P, Rozman D, Prough RA, Meyer UA, Monostory K 2007 Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab. Dispos. 35: 1495-1501. *

• Kohle C, Bock KW 2008 Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem. Pharmacol. Jul 5 [Epub ahead of print]. *

• Koike C, Moore R, Negishi M 2005 Localization of the nuclear receptor CAR at the cell membrane of mouse liver. FEBS Lett. 579: 6733-6736. *

• Konno Y, Negishi M, Kodama S 2008 The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab. Pharmacokinet. 23: 8-13. *

• Korjamo T, Monkkonen J, Uusitalo J, Turpeinen M, Pelkonen O, Honkakoski P 2006 Metabolic and efflux properties of Caco-2 cells stably transfected with nuclear receptors. Pharm. Res. 23: 1991-2001. *

• Krasowski MD, Yasuda K, Hagey LR, Schuetz EG 2005 Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors). Nucl. Recept. 3: 2. *

• Kretschmer XC, Baldwin WS 2005 CAR and PXR: xenosensors of endocrine disrupters? Chem. Biol. Interact. 155: 111-128. *

• Kruger KA, Blum JW, Greger DL 2005 Expression of nuclear receptor and target genes in liver and intestine of neonatal calves fed colostrum and vitamin A. J. Dairy Sci. 88: 3971-3981. *

• Kullak-Ublick GA, Becker MB 2003 Regulation of drug and bile salt transporters in liver and intestine. Drug Metab. Rev. 35: 305-317.

• Lamba J, Lamba V, Schuetz E 2005 Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics. Curr. Drug Metab. 6: 369-383.

• Lamba JK, Lamba V, Yasuda K, Lin YS, Assem M, Thompson E, Strom S, Schuetz EG 2004 Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J. Pharmacol. Exp. Ther. 311: 811-821. *

• Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock ML, Fackenthal JD, Rogan PK, Ring B, Wrighton SA, Schuetz EG 2003 Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J. Pharmacol. Exp. Ther. 307: 906-922. *

• Lee CH, Ito Y, Yanagiba Y, Yamanoshita O, Kim H, Zhang SY, Kamijima M, Gonzalez FJ, Nakajima T 2007 Pyrene-induced CYP1A2 and SULT1A1 may be regulated by CAR and not by AhR. Toxicology 238: 147-156. *

• Lee SK, Lee B, Lee JW 2000 Mutations in retinoid X receptor that impair heterodimerization with specific nuclear hormone receptor. J. Biol. Chem. 275: 33522-33526. *

• Lempiainen H, Molnar F, Macias Gonzalez M, Perakyla M, Carlberg C 2005 Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein. Mol. Endocrinol. 19: 2258-2272. *

• Li CC, Lii CK, Liu KL, Yang JJ, Chen HW 2007 DHA down-regulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes by attenuating CAR translocation. Toxicol. Appl. Pharmacol. 225: 329-336. *

• Li CC, Lii CK, Liu KL, Yang JJ, Chen HW 2006 n-6 and n-3 Polyunsaturated fatty acids down-regulate cytochrome P-450 2B1 gene expression induced by phenobarbital in primary rat hepatocytes. J. Nutr. Biochem. 17: 707-715. *

• Li L, Chen T, Stanton J, Sueyoshi T, Negishi M, Wang H 2008 The peripheral benzodiazepine receptor ligand PK11195 is a novel antagonist of human constitutive androstane receptor. Mol. Pharmacol. 74: 443-453.

• Li N, Hartley DP, Cherrington NJ, Klaassen CD 2002 Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4. J. Pharmacol. Exp. Ther. 301: 551-560. *

• Liddle C, Goodwin B 2002 Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR. Semin. Liver Dis. 22: 115-122.

• Lim YP, Huang JD 2008 Interplay of pregnane X receptor with other nuclear receptors on gene regulation. Drug Metab. Pharmacokinet. 23: 14-21. *

• Lombardo L, Pellitteri R, Balazy M, Cardile V 2008 Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs. Curr. Neurovasc. Res. 5: 82-92.

• Luo G, Guenthner T, Gan LS, Humphreys WG 2004 CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr. Drug Metab. 5: 483-505.

• Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT 2003 Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278: 17277-17283. *

• Maglich JM, Sluder AE, Willson TM, Moore JT 2003 Beyond the human genome: examples of nuclear receptor analysis in model organisms and potential for drug discovery. Am. J. Pharmacogenomics 3: 345-353.

• Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA 2002 Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 62: 638-646. *

• Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD 2005 Induction of the Mrp family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab. Dispos. 33: 956-962. *

• Makinen J, Reinisalo M, Niemi K, Viitala P, Jyrkkarinne J, Chung H, Pelkonen O, Honkakoski P 2003 Dual action of oestrogens on the mouse constitutive androstane receptor. Biochem. J. 376: 465-472. *

• Mandlekar S, Hong JL, Kong AN 2006 Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr. Drug Metab. 7: 661-675.

• Martin P, Riley R, Back DJ, Owen A 2008 Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells. Br. J. Pharmacol. 153: 805-819. *

• Masson D, Qatanani M, Sberna AL, Xiao R, Pais de Barros JP, Grober J, Deckert V, Athias A, Gambert P, Lagrost L, Moore DD, Assem M 2008 Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice. J. Lipid Res. 49: 1682-1691. *

• Meijerman I, Beijnen JH, Schellens JH 2006 Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 11: 742-752. *

• Meyer UA 2006 Porphyrias. Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 30. *

• Miao J, Fang S, Bae Y, Kemper JK 2006 Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J. Biol. Chem. 281: 14537-14546. *

• Min G 2006 Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types. Ann. N. Y. Acad. Sci. 1091: 244-257. *

• Min G 2006 Effects of TK promotor and hepatocyte nuclear factor-4 in CAR-mediated transcriptional activity of phenobarbital responsive unit of CYP2B gene in monkey kidney epithelial-derived cell line COS-7. Ann. N. Y. Acad. Sci. 1091: 258-269. *

• Molnar F, Matilainen M, Carlberg C 2005 Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators. J. Biol. Chem. 280: 26543-26556. *

• Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, Kliewer SA 2006 International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnane X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol. Rev. 58: 742-759. *

• Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, Lambert MH, Moore JT 2002 Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol. Endocrinol. 16: 977-986. *

• Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA 2000 Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275: 15122-15127. *

• Moreau A, Maurel P, Vilarem MJ, Pascussi JM 2007 Constitutive androstane receptor-vitamin D receptor crosstalk: consequence on CYP24 gene expression. Biochem. Biophys. Res. Commun. 360: 76-82. *

• Moreau A, Vilarem MJ, Maurel P, Pascussi JM 2008 Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol. Pharm. 5: 35-41. *

• Muangmoonchai R, Smirlis D, Wong SC, Edwards M, Phillips IR, Shephard EA 2001 Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1. Biochem. J. 355: 71-78. *

• Omura K, Kiyosawa N, Uehara T, Hirode M, Shimizu T, Miyagishima T, Ono A, Nagao T, Urushidani T 2007 Gene expression profiling of rat liver treated with serum triglyceride-decreasing compounds. J. Toxicol. Sci. 32: 387-399. *

• Oscarson M, Zanger UM, Rifki OF, Klein K, Eichelbaum M, Meyer UA 2006 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin. Pharmacol. Ther. 80: 440-456, e7. *

• Oude Elferink R 2004 Yin Zhi Huang and other plant-derived preparations: where herbal and molecular medicine meet. J. Hepatol. 41: 691-693. *

• Palut D, Kostka G, Strucinski P 2002 The role of nuclear receptors in cytochrome P-450 induction by xenochemicals. Rocz. Panstw. Zakl. Hig. 53: 321-332.

• Pascussi JM, Busson-Le Coniat M, Maurel P, Vilarem MJ 2003 Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol. Endocrinol. 17: 42-55. *

• Pascussi JM, Dvorak Z, Gerbal-Chaloin S, Assenat E, Maurel P, Vilarem MJ 2003 Pathophysiological factors affecting CAR gene expression. Drug Metab. Rev. 35: 255-268.

• Pascussi JM, Gerbal-Chaloin S, Drocourt L, Maurel P, Vilarem MJ 2003 The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim. Biophys. Acta 1619: 243-253. *

• Pascussi JM, Gerbal-Chaloin S, Duret C, Daujat-Chavanieu M, Vilarem MJ, Maurel P 2008 The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu. Rev. Pharmacol. Toxicol. 48: 1-32. *

• Pascussi JM, Gerbal-Chaloin S, Fabre JM, Maurel P, Vilarem MJ 2000 Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol. Pharmacol. 58: 1441-1450. *

• Pascussi JM, Robert A, Moreau A, Ramos J, Bioulac-Sage P, Navarro F, Blanc P, Assenat E, Maurel P, Vilarem MJ 2007 Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4alpha isoforms. Hepatology 45: 1146-1153. *

• Pascussi JM, Vilarem MJ 2008 Molecular mechanisms linking xenobiotic metabolism and inflammation. Med. Sci. (Paris) 24: 301-305.

• Patel RD, Hollingshead BD, Omiecinski CJ, Perdew GH 2007 Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Hepatology 46: 209-218. *

• Peffer RC, Moggs JG, Pastoor T, Currie RA, Wright J, Milburn G, Waechter F, Rusyn I 2007 Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicol. Sci. 99: 315-325. *

• Petrick JS, Klaassen CD 2007 Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab. Dispos. 35: 1806-1815. *

• Phillips JM, Yamamoto Y, Negishi M, Maronpot RR, Goodman JI 2007 Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis. Toxicol. Sci. 96: 72-82. *

• Podvinec M, Handschin C, Looser R, Meyer UA 2004 Identification of the xenosensors regulating human 5-aminolevulinate synthase. Proc. Natl. Acad. Sci. U.S.A. 101: 9127-9132. *

• Poso A, Honkakoski P 2006 Ligand recognition by drug-activated nuclear receptors PXR and CAR: structural, site-directed mutagenesis and molecular modeling studies. Mini. Rev. Med. Chem. 6: 937-947.

• Pratt DS 2005 Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 21: 270-274.

• Qatanani M, Moore DD 2005 CAR, the continuously advancing receptor, in drug metabolism and disease. Curr. Drug Metab. 6: 329-339.

• Qatanani M, Wei P, Moore DD 2004 Alterations in the distribution and orexigenic effects of dexamethasone in CAR-null mice. Pharmacol. Biochem. Behav. 78: 285-291. *

• Qatanani M, Zhang J, Moore DD 2005 Role of the constitutive androstane receptor in xenobiotic induced thyroid hormone metabolism. Endocrinology 146: 995-1002. *

• Raunio H, Hakkola J, Pelkonen O 2005 Regulation of CYP3A genes in the human respiratory tract. Chem. Biol. Interact. 151: 53-62. *

• Rencurel F, Foretz M, Kaufmann MR, Stroka D, Looser R, Leclerc I, da Silva Xavier G, Rutter GA, Viollet B, Meyer UA 2006 Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol. Pharmacol. 70: 1925-1934. *

• Reschly EJ, Krasowski MD 2006 Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr. Drug Metab. 7: 349-365.

• Robertson GR, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C 2003 Transgenic mouse models of human CYP3A4 gene regulation. Mol. Pharmacol. 64: 42-50. *

• Rosen MB, Abbott BD, Wolf DC, Corton JC, Wood CR, Schmid JE, Das KP, Zehr RD, Blair ET, Lau C 2008 Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid (PFOA). Toxicol. Pathol. 36: 592-607.

• Roth A, Looser R, Kaufmann M, Blaettler S, Rencurel F, Huang W, Moore DD, Meyer UA 2008 Regulatory crosstalk between drug metabolism and lipid homeostasis: CAR and PXR increase Insig-1 expression. Mol. Pharmacol. 73: 1282-1289. *

• Roth A, Looser R, Kaufmann M, Meyer UA 2008 Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes. Pharmacogenet. Genomics 18: 325-337.

• Runge-Morris M, Kocarek TA 2005 Regulation of sulfotransferases by xenobiotic receptors. Curr. Drug Metab. 6: 299-307.

• Rushmore TH, Kong AN 2002 Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 3: 481-490.

• Rutherford AE, Pratt DS 2006 Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 22: 209-214.

• Saini SP, Mu Y, Gong H, Toma D, Uppal H, Ren S, Li S, Poloyac SM, Xie W 2005 Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology 41: 497-505. *

• Saini SP, Sonoda J, Xu L, Toma D, Uppal H, Mu Y, Ren S, Moore DD, Evans RM, Xie W 2004 A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol. Pharmacol. 65: 292-300. *

• Sakai H, Iwata H, Kim EY, Tsydenova O, Miyazaki N, Petrov EA, Batoev VB, Tanabe S 2006 Constitutive androstane receptor (CAR) as a potential sensing biomarker of persistent organic pollutants (POPs) in aquatic mammal: molecular characterization, expression level and ligand profiling in Baikal Seal (Pusa sibirica). Toxicol. Sci. 94: 57-70. *

• Sarkar J, Qi C, Guo D, Ahmed MR, Jia Y, Usuda N, Viswakarma N, Rao MS, Reddy JK 2007 Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PPARalpha and CAR, the constitutive androstane receptor, in mouse liver. Gene Expr. 13: 255-269.

• Saussele T, Burk O, Blievernicht JK, Klein K, Nussler A, Nussler N, Hengstler JG, Eichelbaum M, Schwab M, Zanger UM 2007 Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole. Clin. Pharmacol. Ther. 82: 265-274.

• Savkur RS, Wu Y, Bramlett KS, Wang M, Yao S, Perkins D, Totten M, Searfoss G 3rd, Ryan TP, Su EW, Burris TP 2003 Alternative splicing within the ligand binding domain of the human constitutive androstane receptor. Mol. Genet. Metab. 80: 216-226. *

• Scheer N, Ross J, Rode A, Zevnik B, Niehaves S, Faust N, Wolf CR 2008 A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J. Clin. Invest. 118: 3228-3239. *

• Seo YK, Chung YT, Kim S, Echchgadda I, Song CS, Chatterjee B 2007 Xenobiotic- and vitamin D-responsive induction of the steroid/bile acid-sulfotransferase Sult2A1 in young and old mice: the role of a gene enhancer in the liver chromatin. Gene 386: 218-223. *

• Shan L, Vincent J, Brunzelle JS, Dussault I, Lin M, Ianculescu I, Sherman MA, Forman BM, Fernandez EJ 2004 Structure of the murine constitutive androstane receptor complexed to androstenol; a molecular basis for inverse agonism. Mol. Cell. 16: 907-917. *

• Shelby MK, Klaassen CD 2006 Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Drug Metab. Dispos. 34: 1772-1778. *

• Shibayama Y, Ushinohama K, Ikeda R, Yoshikawa Y, Motoya T, Takeda Y, Yamada K 2006 Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats. Cancer Sci. 97: 1260-1266. *

• Shindo S, Numazawa S, Yoshida T 2007 A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction. Biochem. J. 401: 735-741. *

• Shiraki T, Sakai N, Kanaya E, Jingami H 2003 Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. J. Biol. Chem. 278: 11344-11350. *

• Simonsson US, Lindell M, Raffalli-Mathieu F, Lannerbro A, Honkakoski P, Lang MA 2006 In vivo and mechanistic evidence of nuclear receptor CAR induction by artemisinin. Eur. J. Clin. Invest. 36: 647-653. *

• Sinclair PA, Gilmore WJ, Lin Z, Lou Y, Squires EJ 2006 Molecular cloning and regulation of porcine SULT2A1: relationship between SULT2A1 expression and sulfoconjugation of androstenone. J. Mol. Endocrinol. 36: 301-311. *

• Slatter JG, Cheng O, Cornwell PD, De Souza A, Rockett J, Rushmore T, Hartley D, Evers R, He Y, Dai X, Hu R, Caguyong M, Roberts CJ, Castle J, Ulrich RG 2006 Microarray-based compendium of hepatic gene expression profiles for prototypical ADME gene-inducing compounds in rats and mice in vivo. Xenobiotica 36: 902-937. *

• Slitt AL, Cherrington N, Fisher C, Negishi M, Klaassen CD 2006 Induction of genes for metabolism and transport by trans-stilbene oxide in livers of Sprague-Dawley and Wistar-Kyoto Rats. Drug Metab. Dispos. 34: 1190-1197. *

• Slitt AL, Cherrington NJ, Dieter MZ, Huang W, Aleksunes LM, Scheffer GL, Moore DD, Klaassen CD 2006 Trans-stilbene oxide induces expression of genes involved in metabolism and disposition in mouse liver via CAR and Nrf2 transcription factors. Mol. Pharmacol. 69: 1554-1563. *

• Smirlis D, Muangmoonchai R, Edwards M, Phillips IR, Shephard EA 2001 Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics. J. Biol. Chem. 276: 12822-12826. *

• Sonoda J, Chong LW, Downes M, Barish GD, Coulter S, Liddle C, Lee CH, Evans RM 2005 Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc. Natl. Acad. Sci. U.S.A. 102: 2198-2203. *

• Sonoda J, Evans RM 2003 Biological function and mode of action of nuclear xenobiotic receptors. Pure Appl. Chem. 75: 1733-1742. *

• Staudinger JL, Madan A, Carol KM, Parkinson A 2003 Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. 31: 523-527. *

• Stedman CA, Liddle C, Coulter SA, Sonoda J, Alvarez JG, Moore DD, Evans RM, Downes M 2005 Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc. Natl. Acad. Sci. U.S.A. 102: 2063-2068. *

• Stoner MA, Auerbach SS, Zamule SM, Strom SC, Omiecinski CJ 2007 Transactivation of a DR-1 PPRE by a human constitutive androstane receptor variant expressed from internal protein translation start sites. Nucleic Acids Res. 35: 2177-2190. *

• Su T, Ding X 2004 Regulation of the cytochrome P450 2A genes. Toxicol. Appl. Pharmacol. 199: 285-294. *

• Sugatani J, Mizushima K, Osabe M, Yamakawa K, Kakizaki S, Takagi H, Mori M, Ikari A, Miwa M 2008 Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter. Naunyn. Schmiedebergs. Arch. Pharmacol. 377: 597-605. *

• Sugatani J, Nishitani S, Yamakawa K, Yoshinari K, Sueyoshi T, Negishi M, Miwa M 2005 Transcriptional regulation of human UGT1A1 gene expression: activated GR enhances CAR/PXR-mediated UGT1A1 regulation with GRIP1. Mol. Pharmacol. 67: 845-855. *

• Sugatani J, Sueyoshi T, Negishi M, Miwa M 2005 Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocorticoid receptor. Methods Enzymol. 400: 92-104.

• Sugatani J, Yamakawa K, Tonda E, Nishitani S, Yoshinari K, Degawa M, Abe I, Noguchi H, Miwa M 2004 The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem. Pharmacol. 67: 989-1000.

• Suh JI 2006 Role of PXR and CAR in cholestasis. Korean J. Hepatol. 12: 5-15.

• Suino K, Peng L, Reynolds R, Li Y, Cha JY, Repa JJ, Kliewer SA, Xu HE 2004 The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol. Cell 16: 893-905. *

• Surapureddi S, Rana R, Reddy JK, Goldstein JA 2008 The coactivator NCOA6 mediates the synergistic activation of human cytochrome P-450 2C9 by the constitutive androstane receptor and hepatic nuclear factor-4alpha. Mol. Pharmacol. 74: 913-923. *

• Sweeney TR, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR 2006 Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am. J. Physiol. Endocrinol. Metab. 290: E1313-E1320. *

• Takeyama Y, Uehara Y, Inomata S, Morihara D, Nishizawa S, Ueda S, Matsumoto T, Tanaka T, Anan A, Nishimura H, Irie M, Iwata K, Shakado S, Sohda T, Sakisaka S 2008 Alternative transporter pathways in patients with untreated early-stage and late-stage primary biliary cirrhosis. Liver Int. Jul 24 [Epub ahead of print]. *

• Tham LS, Holford NH, Hor SY, Tan T, Wang L, Lim RC, Lee HS, Lee SC, Goh BC 2007 Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics. Clin. Cancer Res. 13: 7126-7132. *

• Thasler WE, Dayoub R, Muehlbauer M, Hellerbrand C, Singer T, Graebe A, Jauch KW, Schlitt HJ, Weiss TS 2006 Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor Augmenter of Liver Regeneration. J. Pharmacol. Exp. Ther. 316: 822-829. *

• Thompson EE, Kuttab-Boulos H, Krasowski MD, Di Rienzo A 2005 Functional constraints on the constitutive androstane receptor inferred from human sequence variation and cross-species comparisons. Hum. Genomics 2: 168-178. *

• Tien ES, Matsui K, Moore R, Negishi M 2007 The nuclear receptor constitutively active/androstane receptor regulates type 1 deiodinase and thyroid hormone activity in the regenerating mouse liver. J. Pharmacol. Exp. Ther. 320: 307-313. *

• Tirona RG, Kim RB 2005 Nuclear receptors and drug disposition gene regulation. J. Pharm. Sci. 94: 1169-1186. *

• Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, Schuetz EG, Kim RB 2003 The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med. 9: 220-224. *

• Toell A, Kroncke KD, Kleinert H, Carlberg C 2002 Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands. J. Cell. Biochem. 85: 72-82. *

• Tompkins LM, Wallace AD 2007 Mechanisms of cytochrome P450 induction. J. Biochem. Mol. Toxicol. 21: 176-181.

• Trauner M 2004 The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope? Hepatology 40: 260-263. *

• Trottier J, Milkiewicz P, Kaeding J, Verreault M, Barbier O 2006 Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol. Pharm. 3: 212-222. *

• Vaccarino AL, Paul D, Mukherjee PK, Rodriguez de Turco EB, Marcheselli VL, Xu L, Trudell ML, Minguez JM, Matia MP, Sunkel C, Alvarez-Builla J, Bazan NG 2007 Synthesis and in vivo evaluation of non-hepatotoxic acetaminophen analogs. Bioorg. Med. Chem. 15: 2206-2215.

• Vincent J, Shan L, Fan M, Brunzelle JS, Forman BM, Fernandez EJ 2005 Crystallographic analysis of murine constitutive androstane receptor ligand-binding domain complexed with 5alpha-androst-16-en-3alpha-ol. Acta Crystallograph. Sect. F. Struct. Biol. Cryst. Commun. 61: 156-159.

• Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M 2005 CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42: 420-430. *

• Wang H, Faucette S, Sueyoshi T, Moore R, Ferguson S, Negishi M, LeCluyse EL 2003 A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J. Biol. Chem. 278: 14146-14152. *

• Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M, LeCluyse EL 2003 Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metab. Dispos. 31: 620-630. *

• Wang H, LeCluyse EL 2003 Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin. Pharmacokinet. 42: 1331-1357.

• Wang H, Negishi M 2003 Transcriptional regulation of cytochrome P450 2B genes by nuclear receptors. Curr. Drug Metab. 4: 515-525.

• Wei P, Zhang J, Dowhan DH, Han Y, Moore DD 2002 Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J. 2: 117-126. *

• Weng Y, Dirusso CC, Reilly AA, Black PN, Ding X 2005 Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene: mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype. J. Biol. Chem. 280: 31686-31698. *

• Westerink WM, Schoonen WG 2007 Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro 21: 1581-1591.

• Willson TM, Kliewer SA 2002 PXR, CAR and drug metabolism. Nat. Rev. Drug Discov. 1: 259-266. *

• Windshugel B, Jyrkkarinne J, Poso A, Honkakoski P, Sippl W 2005 Molecular dynamics simulations of the human CAR ligand-binding domain: deciphering the molecular basis for constitutive activity. J. Mol. Model. (Online) 11: 69-79. *

• Windshugel B, Jyrkkarinne J, Vanamo J, Poso A, Honkakoski P, Sippl W 2007 Comparison of homology models and X-ray structures of the nuclear receptor CAR: assessing the structural basis of constitutive activity. J. Mol. Graph Model. 25: 644-657. *

• Wong H, Lehman-McKeeman LD, Grubb MF, Grossman SJ, Bhaskaran VM, Solon EG, Shen HS, Gerson RJ, Car BD, Zhao B, Gemzik B 2005 Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats. Toxicol. Sci. 84: 232-242. *

• Wortham M, Czerwinski M, He L, Parkinson A, Wan YJ 2007 Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab. Dispos. 35: 1700-1710. *

• Wright E, Vincent J, Fernandez EJ 2007 Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry. Biochemistry 46: 862-870. *

• Wyde ME, Bartolucci E, Ueda A, Zhang H, Yan B, Negishi M, You L 2003 The environmental pollutant 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene induces rat hepatic cytochrome P450 2B and 3A expression through the constitutive androstane receptor and pregnane X receptor. Mol. Pharmacol. 64: 474-481. *

• Wyde ME, Kirwan SE, Zhang F, Laughter A, Hoffman HB, Bartolucci-Page E, Gaido KW, Yan B, You L 2005 Di-n-butyl phthalate activates constitutive androstane receptor and pregnane X receptor and enhances the expression of steroid-metabolizing enzymes in the liver of rat fetuses. Toxicol. Sci. 86: 281-290. *

• Xia J, Kemper B 2007 Subcellular trafficking signals of constitutive androstane receptor: evidence for a nuclear export signal in the DNA binding domain. Drug Metab. Dispos. 35: 1489-1494. *

• Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM 2000 Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14: 3014-3023. *

• Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS, Cabrera GY, Tukey RH, Evans RM 2003 Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. U.S.A. 100: 4150-4155. *

• Xu C, Li CY, Kong AN 2005 Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28: 249-268.

• Xu RX, Lambert MH, Wisely BB, Warren EN, Weinert EE, Waitt GM, Williams JD, Collins JL, Moore LB, Willson TM, Moore JT 2004 A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol. Cell. 16: 919-928. *

• Yamada H, Ishii Y, Yamamoto M, Oguri K 2006 Induction of the hepatic cytochrome P450 2B subfamily by xenobiotics: research history, evolutionary aspect, relation to tumorigenesis, and mechanism. Curr. Drug Metab. 7: 397-409.

• Yamazaki Y, Kakizaki S, Horiguchi N, Sohara N, Sato K, Takagi H, Mori M, Negishi M 2007 The role of nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis. Gut 56: 565-574. *

• Yoshinari K 2006 Roles of nuclear receptors in the gene expression of drug-metabolizing enzymes under various physiological conditions. Yakugaku Zasshi 126: 343-348.

• Yoshinari K, Takagi S, Sugatani J, Miwa M 2006 Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice. Biol. Pharm. Bull. 29: 1634-1638. *

• You L 2004 Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. Chem. Biol. Interact. 147: 233-246. *

• Yu C, Ye S, Sun H, Liu Y, Gao L, Shen C, Chen S, Zeng S 2008 PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chem. Biol. Interact. Sep 2 [Epub ahead of print].

• Zhai Y, Pai HV, Zhou J, Amico JA, Vollmer RR, Xie W 2007 Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol. Endocrinol. 21: 138-147. *

• Zhang J, Huang W, Chua SS, Wei P, Moore DD 2002 Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298: 422-424. *

• Zhang J, Huang W, Qatanani M, Evans RM, Moore DD 2004 The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J. Biol. Chem. 279: 49517-49522. *

• Zhang Q, Bae Y, Kemper JK, Kemper B 2006 Analysis of multiple nuclear receptor binding sites for CAR/RXR in the phenobarbital responsive unit of CYP2B2. Arch. Biochem. Biophys. 451: 119-127. *

• Zhou J, Zhang J, Xie W 2005 Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases. Curr. Drug Metab. 6: 289-298.

• Zollner G, Wagner M, Fickert P, Silbert D, Gumhold J, Zatloukal K, Denk H, Trauner M 2007 Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int. 27: 920-929. *

Number of references = 270

www psc-literature.org